AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28270180 — intervention group
Group type: COMPARATOR
Intervention: Control (no visit)
Number of subjects: 150
Study 26009822 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective evaluation of sublingual microcirculation images by physicians and nurses
Number of subjects: 106
Study 23534046 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorinex treatment
Number of subjects: 20
Study 23534046 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated teeth)
Number of subjects: 20
Study 21636013 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin B₆ intake (median daily intake of 0.9 mg/day, range 0.6-1.5 mg/day)
Number of subjects: 17
Study 21636013 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 17
Study 18499601 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol/remifentanil
Number of subjects: 40
Study 18499601 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 40
Study 16595616 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan (24 microg kg(‐1) infused i.v. over a 10 min period)
Number of subjects: 24
Study 16595616 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 14663295 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (ET) for 6 months
Number of subjects: 73
Study 10891912 — intervention group
Group type: EXPERIMENTAL
Intervention: Naratriptan 1.5 mg
Number of subjects: 34
Study 10891912 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 8838506 — intervention group
Group type: EXPERIMENTAL
Intervention: Rheumatoid arthritis (RA) patients receiving low dose methotrexate (MTX)
Number of subjects: 26
Study 8838506 — intervention group
Group type: COMPARATOR
Intervention: Rheumatoid arthritis (RA) patients not receiving low dose methotrexate (MTX)
Number of subjects: 26
Study 8838506 — intervention group
Group type: COMPARATOR
Intervention: Controls (healthy individuals), n = 26
Number of subjects: 26
Study 8838506 — intervention group
Group type: EXPERIMENTAL
Intervention: Rheumatoid arthritis (RA) patients with positive serum tests for RF
Number of subjects: 26
Study 8838506 — intervention group
Group type: EXPERIMENTAL
Intervention: Rheumatoid arthritis (RA) patients with HLA‐DR4 positive genotype
Number of subjects: 26
Study 8838506 — intervention group
Group type: EXPERIMENTAL
Intervention: Rheumatoid arthritis (RA) patients overall
Number of subjects: 26
Study 1486071 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3% ofloxacin solution
Number of subjects: 104
Study 1486071 — intervention group
Group type: COMPARATOR
Intervention: 0.3% gentamicin ophthalmic solution
Number of subjects: 104
Study 3988433 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-learning packages
Number of subjects: 0
Study 3988433 — intervention group
Group type: COMPARATOR
Intervention: Small group seminars
Number of subjects: 0
Study 3988433 — intervention group
Group type: COMPARATOR
Intervention: Lectures
Number of subjects: 0
Study 30191262 — intervention group
Group type: EXPERIMENTAL
Intervention: Laquinimod (0.6 mg/day)
Number of subjects: 48
Study 30191262 — intervention group
Group type: COMPARATOR
Intervention: Combined oral contraceptives (COC)
Number of subjects: 48
Study 29526474 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga intervention
Number of subjects: 0
Study 29526474 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 0
Study 27210427 — intervention group
Group type: EXPERIMENTAL
Intervention: GS-4774 2 YU
Number of subjects: 178
Study 27210427 — intervention group
Group type: EXPERIMENTAL
Intervention: GS-4774 10 YU
Number of subjects: 178
Study 27210427 — intervention group
Group type: EXPERIMENTAL
Intervention: GS-4774 40 YU
Number of subjects: 178
Study 27210427 — intervention group
Group type: COMPARATOR
Intervention: OAV alone (Control)
Number of subjects: 178
Study 25515217 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted quality improvement intervention for CVD risk management including electronic decision support, patient risk communication tools, computerized audit and feedback tools, and monthly peer-ranked performance feedback via a web portal.
Number of subjects: 60
Study 25515217 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted quality improvement intervention for CVD risk management.
Number of subjects: 60
Study 22835059 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C (Cell Saver 5+)
Number of subjects: 30
Study 22835059 — intervention group
Group type: EXPERIMENTAL
Intervention: Group M (autolog)
Number of subjects: 30
Study 22835059 — intervention group
Group type: COMPARATOR
Intervention: Group F (CATS)
Number of subjects: 30
Study 20174803 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Thyroidectomy (TT)
Number of subjects: 600
Study 20174803 — intervention group
Group type: EXPERIMENTAL
Intervention: Dunhill operation (DO)
Number of subjects: 600
Study 20174803 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral Subtotal Thyroidectomy (BST)
Number of subjects: 600
Study 17196208 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline 400mg TID for 6 months
Number of subjects: 64
Study 17196208 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 64
Study 15948681 — intervention group
Group type: EXPERIMENTAL
Intervention: HF-DDS graft
Number of subjects: 13
Study 15948681 — intervention group
Group type: COMPARATOR
Intervention: CTG
Number of subjects: 13
Study 15948681 — intervention group
Group type: EXPERIMENTAL
Intervention: HF-DDS (single thickness)
Number of subjects: 13
Study 15948681 — intervention group
Group type: EXPERIMENTAL
Intervention: HF-DDS and CTG
Number of subjects: 13
Study 11443558 — intervention group
Group type: EXPERIMENTAL
Intervention: M. bovis BCG vaccination
Number of subjects: 616
Study 11443558 — intervention group
Group type: COMPARATOR
Intervention: Control group (no BCG vaccination)
Number of subjects: 616
Study 9570608 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.06% bupivacaine with sufentanil
Number of subjects: 60
Study 9570608 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12% bupivacaine with sufentanil
Number of subjects: 60
Study 9570608 — intervention group
Group type: COMPARATOR
Intervention: sufentanil alone
Number of subjects: 60
Study 7985829 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g fish oil (group A)
Number of subjects: 39
Study 7985829 — intervention group
Group type: COMPARATOR
Intervention: 10 g placebo Italian olive oil (group B)
Number of subjects: 39
Study 2658392 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg at night
Number of subjects: 12
Study 2658392 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 31814599 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV analysis in heavy smokers
Number of subjects: 60
Study 31814599 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV types 6 and 16
Number of subjects: 60
Study 31814599 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV infections in pre-neoplastic conditions versus cancer
Number of subjects: 60
Study 31814599 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking and alcohol consumption
Number of subjects: 60
Study 31814599 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced T stage
Number of subjects: 60
Study 29071755 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatherapy massage with lavender essential oil
Number of subjects: 90
Study 29071755 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 90
Study 26093363 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive periodontal disease treatment during mid-pregnancy (20-28 weeks' gestation)
Number of subjects: 80
Study 26093363 — intervention group
Group type: COMPARATOR
Intervention: Control group (same treatment postnatally)
Number of subjects: 80
Study 26093363 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive periodontal disease treatment
Number of subjects: 80
Study 26093363 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study 26093363 — intervention group
Group type: EXPERIMENTAL
Intervention: Severity of periodontal disease
Number of subjects: 80
Study 24434527 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion 150 mg/d as an open-label add-on therapy (n = 5)
Number of subjects: 12
Study 24434527 — intervention group
Group type: COMPARATOR
Intervention: Previous treatment (valproate and aripiprazole) without bupropion (n = 7)
Number of subjects: 12
Study 23031335 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blocker treatment for 3 months
Number of subjects: 62
Study 23031335 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined alpha/beta-blocker treatment for 3 months
Number of subjects: 62
Study 23031335 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 62
Study 19250152 — intervention group
Group type: EXPERIMENTAL
Intervention: Online cognitive behavioural therapy (CBT)
Number of subjects: 24
Study 17502744 — intervention group
Group type: EXPERIMENTAL
Intervention: balafilcon A
Number of subjects: 25
Study 17502744 — intervention group
Group type: EXPERIMENTAL
Intervention: lotrafilcon A
Number of subjects: 25
Study 17502744 — intervention group
Group type: EXPERIMENTAL
Intervention: no lens wear
Number of subjects: 25
Study 17502744 — intervention group
Group type: EXPERIMENTAL
Intervention: etafilcon A
Number of subjects: 25
Study 17502744 — intervention group
Group type: COMPARATOR
Intervention: senofilcon A
Number of subjects: 25
Study 15007010 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (20 minutes of bicycle ergometry per day for 12 months)
Number of subjects: 101
Study 15007010 — intervention group
Group type: COMPARATOR
Intervention: Standard percutaneous coronary intervention (PCI) with stenting
Number of subjects: 101
Study 11529364 — intervention group
Group type: EXPERIMENTAL
Intervention: Kenacort‐A injection into the right tonsillar fossa
Number of subjects: 50
Study 11529364 — intervention group
Group type: COMPARATOR
Intervention: Control (left side, no intervention)
Number of subjects: 50
Study 9738383 — intervention group
Group type: EXPERIMENTAL
Intervention: ICCE with AC IOL
Number of subjects: 2000
Study 9738383 — intervention group
Group type: COMPARATOR
Intervention: ICCE with aphakic correction (control group)
Number of subjects: 2000
Study 8109906 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin-A (botox)
Number of subjects: 2
Study 2732408 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfite-treated lettuce (sodium bisulfite freshener)
Number of subjects: 5
Study 2732408 — intervention group
Group type: COMPARATOR
Intervention: Control (lettuce treated with freshener containing no sulfite)
Number of subjects: 5
Study 30106532 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothpaste with Novamin (1,426 ppmF)
Number of subjects: 10
Study 30106532 — intervention group
Group type: COMPARATOR
Intervention: Control toothpaste (1,450 ppmF)
Number of subjects: 10
Study 30106532 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothpaste with Arginine and calcium carbonate (1,450 ppmF)
Number of subjects: 10
Study 30106532 — intervention group
Group type: EXPERIMENTAL
Intervention: All tested dentifrices
Number of subjects: 10
Study 28089149 — intervention group
Group type: EXPERIMENTAL
Intervention: Early eptifibatide
Number of subjects: 2240
Study 28089149 — intervention group
Group type: COMPARATOR
Intervention: Delayed, provisional use of eptifibatide
Number of subjects: 2240
Study 28089149 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting glucose
Number of subjects: 2240
Study 28089149 — intervention group
Group type: EXPERIMENTAL
Intervention: NT-proBNP
Number of subjects: 2240
Study 26122726 — intervention group
Group type: EXPERIMENTAL
Intervention: Biosimilar filgrastim (EP2006)
Number of subjects: 218
Study 26122726 — intervention group
Group type: COMPARATOR
Intervention: Reference filgrastim (Neupogen)
Number of subjects: 218
Study 23515949 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadofosveset trisodium (MS-325; Lantheus Med, 0.03 mmol/Kg)
Number of subjects: 22
Study 23515949 — intervention group
Group type: COMPARATOR
Intervention: Gadobenate dimeglumine (Gd-BOPTA; Bracco, 0.1 mmol/Kg)
Number of subjects: 22
Study 21872998 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline with flexible quit date (FQD) approach
Number of subjects: 0
Study 21872998 — intervention group
Group type: COMPARATOR
Intervention: Varenicline with target quit date (TQD) approach
Number of subjects: 0
Study 19752608 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrarectal lidocaine gel and 5 ml bupivacaine (0.25%) injected into periprostatic area
Number of subjects: 100
Study 19752608 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrarectal lidocaine gel and 5 ml ropivacaine (0.25%) injected into periprostatic area
Number of subjects: 100
Study 19752608 — intervention group
Group type: COMPARATOR
Intervention: Intrarectal lidocaine gel
Number of subjects: 100
Study 19752608 — intervention group
Group type: COMPARATOR
Intervention: No local anesthesia
Number of subjects: 100
Study 17697548 — intervention group
Group type: EXPERIMENTAL
Intervention: TACE plus thalidomide (200 mg/d for 1-6 months)
Number of subjects: 108
Study 17697548 — intervention group
Group type: COMPARATOR
Intervention: TACE alone
Number of subjects: 108
Study 14973801 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron supplementation with iron III‐hydroxide sucrose complex (IHSC)
Number of subjects: 120
Study 14973801 — intervention group
Group type: EXPERIMENTAL
Intervention: IV iron and a single dose of r‐HuEPO (300 U/kg)
Number of subjects: 120
Study 14973801 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 120
Study 11214126 — intervention group
Group type: EXPERIMENTAL
Intervention: 1500 mg sulphate oral glucosamine once daily for 3 years
Number of subjects: 212
Study 11214126 — intervention group
Group type: COMPARATOR
Intervention: Placebo once daily for 3 years
Number of subjects: 212
Study 11214126 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 212
Study 8783377 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ)
Number of subjects: 48
Study 8783377 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenytoin (PHT)
Number of subjects: 48
Study 8783377 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproate (VPA)
Number of subjects: 48
Study 8783377 — intervention group
Group type: EXPERIMENTAL
Intervention: Zonisamide (ZNS)
Number of subjects: 48
Study 2272187 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled-release indomethacin (75 mg)
Number of subjects: 84
Study 2272187 — intervention group
Group type: COMPARATOR
Intervention: Sustained-release diclofenac sodium (100 mg)
Number of subjects: 84
Study 6937788 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 ml cows' milk (double-blind challenge)
Number of subjects: 23
Study 31104033 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized FRC post with 37% H3PO4 etching
Number of subjects: 90
Study 31104033 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized FRC post with 19% EDTA etching
Number of subjects: 90
Study 31104033 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized FRC post with control etching
Number of subjects: 90
Study 31104033 — intervention group
Group type: EXPERIMENTAL
Intervention: Root canal reshaping with 37% H3PO4 etching
Number of subjects: 90
Study 31104033 — intervention group
Group type: EXPERIMENTAL
Intervention: Root canal reshaping with 19% EDTA etching
Number of subjects: 90
Study 31104033 — intervention group
Group type: EXPERIMENTAL
Intervention: Root canal reshaping with control etching
Number of subjects: 90
Study 31104033 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 90
Study 28502735 — intervention group
Group type: EXPERIMENTAL
Intervention: Low calcium dialysate (LCD; 1.25mmol/L)
Number of subjects: 76
Study 28502735 — intervention group
Group type: COMPARATOR
Intervention: Standard calcium dialysate (SCD; 1.5mmol/L)
Number of subjects: 76
Study 25664556 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent functioning related to diabetes care
Number of subjects: 134
Study 25664556 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent mealtime behaviors
Number of subjects: 134
Study 25664556 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes-specific parent functioning
Number of subjects: 134
Study 25664556 — intervention group
Group type: EXPERIMENTAL
Intervention: Child mealtime behaviors
Number of subjects: 134
Study 24662009 — intervention group
Group type: EXPERIMENTAL
Intervention: whole-body periodic acceleration (pGz)
Number of subjects: 17
Study 24662009 — intervention group
Group type: COMPARATOR
Intervention: control group
Number of subjects: 17
Study 22483238 — intervention group
Group type: EXPERIMENTAL
Intervention: Taeumjowi-tang (TJ001) 7 g three times daily for 12 weeks
Number of subjects: 104
Study 22483238 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study 22483238 — intervention group
Group type: EXPERIMENTAL
Intervention: Taeumjowi-tang (TJ001)
Number of subjects: 104
Study 20400000 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal oxygen administration
Number of subjects: 30
Study 20400000 — intervention group
Group type: COMPARATOR
Intervention: Control (no nasal oxygen)
Number of subjects: 30
Study 18074413 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone 4 mg once a day
Number of subjects: 90
Study 18074413 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin 500 mg two times a day
Number of subjects: 90
Study 18074413 — intervention group
Group type: COMPARATOR
Intervention: Control group (no hypoglycemic treatment)
Number of subjects: 90
Study 15651718 — intervention group
Group type: EXPERIMENTAL
Intervention: Right infra-axillary minithoracotomy (Group A; n = 29)
Number of subjects: 59
Study 15651718 — intervention group
Group type: COMPARATOR
Intervention: Conventional median sternotomy (Group B; n = 30)
Number of subjects: 59
Study 11961623 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured training methods (MIST-VR)
Number of subjects: 43
Study 11961623 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured training methods (Box trainer drills)
Number of subjects: 43
Study 11961623 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured training methods (four groups)
Number of subjects: 43
Study 11961623 — intervention group
Group type: EXPERIMENTAL
Intervention: MIST-VR tasks
Number of subjects: 43
Study 10408729 — intervention group
Group type: EXPERIMENTAL
Intervention: MN rgp120 HIV-1 vaccine
Number of subjects: 25
Study 10408729 — intervention group
Group type: EXPERIMENTAL
Intervention: IIIB rgp120 HIV-1 vaccine
Number of subjects: 25
Study 10408729 — intervention group
Group type: EXPERIMENTAL
Intervention: MN rgp120 HIV-1 vaccine (booster)
Number of subjects: 25
Study 10408729 — intervention group
Group type: EXPERIMENTAL
Intervention: MN and IIIB rgp120 HIV-1 vaccines (coadministered)
Number of subjects: 25
Study 8900242 — intervention group
Group type: EXPERIMENTAL
Intervention: Met-985 insulin-receptor variant
Number of subjects: 699
Study 8900242 — intervention group
Group type: COMPARATOR
Intervention: Normal oral glucose tolerance test
Number of subjects: 699
Study 8900242 — intervention group
Group type: EXPERIMENTAL
Intervention: Met-985 carriers
Number of subjects: 699
Study 8900242 — intervention group
Group type: EXPERIMENTAL
Intervention: Total study group analysis
Number of subjects: 699
Study 19186427 — intervention group
Group type: EXPERIMENTAL
Intervention: Copal varnish before the retrofill amalgam
Number of subjects: 60
Study 19186427 — intervention group
Group type: EXPERIMENTAL
Intervention: Copal varnish before and after the retrofill amalgam
Number of subjects: 60
Study 19186427 — intervention group
Group type: EXPERIMENTAL
Intervention: Barrier (polyamide varnish) before the retrofill amalgam
Number of subjects: 60
Study 19186427 — intervention group
Group type: EXPERIMENTAL
Intervention: Barrier before and after the retrofill amalgam
Number of subjects: 60
Study 19186427 — intervention group
Group type: COMPARATOR
Intervention: Retrofill amalgam with no varnish
Number of subjects: 60
Study 6143187 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 ml intradermally at 8 sites
Number of subjects: 98
Study 6143187 — intervention group
Group type: EXPERIMENTAL
Intervention: Various regimens (including multiple sites intradermally or subcutaneously)
Number of subjects: 98
Study 6143187 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-site intradermal vaccination with large dose of HRIG
Number of subjects: 98
Study 30365961 — intervention group
Group type: EXPERIMENTAL
Intervention: CPB flow rate of 2.4 L · min‐1 · m‐2
Number of subjects: 17
Study 30365961 — intervention group
Group type: EXPERIMENTAL
Intervention: CPB flow rate of 2.7 L · min‐1 · m‐2
Number of subjects: 17
Study 30365961 — intervention group
Group type: EXPERIMENTAL
Intervention: CPB flow rate of 3.0 L · min‐1 · m‐2
Number of subjects: 17
Study 30365961 — intervention group
Group type: EXPERIMENTAL
Intervention: CPB flow rates of 2.4, 2.7, and 3.0 L · min‐1 · m‐2
Number of subjects: 17
Study 30285672 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdiagnostic group cognitive-behaviour therapy (tCBT) - 12 weekly 2-hour group sessions following a manualized treatment protocol
Number of subjects: 0
Study 26948161 — intervention group
Group type: EXPERIMENTAL
Intervention: GUM (chewing gum for 15min per hour over 3 hours)
Number of subjects: 50
Study 26948161 — intervention group
Group type: EXPERIMENTAL
Intervention: GUM
Number of subjects: 50
Study 26948161 — intervention group
Group type: COMPARATOR
Intervention: Control (no gum)
Number of subjects: 50
Study 24597608 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast-track surgery combined with laparoscopy
Number of subjects: 120
Study 24597608 — intervention group
Group type: COMPARATOR
Intervention: Conventional perioperative intervention plus laparoscopy
Number of subjects: 120
Study 22647453 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphology plus NIR spectroscopy of embryo culture medium
Number of subjects: 417
Study 22647453 — intervention group
Group type: COMPARATOR
Intervention: Morphology only (control group)
Number of subjects: 417
Study 22647453 — intervention group
Group type: EXPERIMENTAL
Intervention: Embryos with best morphology (selected by embryological technician)
Number of subjects: 417
Study 21055582 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed orthodontic treatment with chemically cured resin
Number of subjects: 26
Study 21055582 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed orthodontic treatment with light-cured resin
Number of subjects: 26